Brooks Laboratories Ltd Share Price
(BROOKS)
Check the latest share price of Brooks Laboratories Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
as on 04:01PM, 12 May 2025
NSE
Brooks Laboratories Ltd Performance
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
₹130Day's Price Range₹135.952 Week's Low
52 Week's High
₹73.2552-Week Price Range₹198.86
| Returns % | |
| 1 Month Return | -6.72 % |
| 3 Month Return | -3.91 % |
| 1 Year Return | + 33.37 % |
| 3 Year Return | + 73.7 % |
| 5 Year Return | + 337.3 % |
| Market Stats | |
| Previous Close | ₹130.97 |
| Open | ₹131.00 |
| Volume | 20.13K |
| Upper Circuit | ₹137.51 |
| Lower Circuit | ₹124.42 |
Brooks Laboratories Ltd Fundamentals & Key Indicators
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹385.80 Cr
Return on Equity (ROE)
1.9
PE Ratio (TTM)
-16.43
Return on capital employed (ROCE)
2.72
Industry PE ratio
53.76
Beta (LTM)
0.69
P/B Ratio
3.5
Dividend Yield
0PEG Ratio
7.04
Quarterly Earnings Growth YOY
17.78
EPS (TTM)
-7.46
Sector
Pharmaceuticals
Book Value
24.99
Technical Analysis
Bullish
View Technical Analysis
How to invest in Brooks Laboratories Ltd
Investing in Brooks Laboratories Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Brooks Laboratories Ltd or BROOKS on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Brooks Laboratories Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Brooks Laboratories Ltd with just a few clicks!
Brooks Laboratories Ltd Stock's Interest Amongst Investors
Brooks Laboratories Ltd Valuation
Track how the P/E of Brooks Laboratories Ltd has moved over time to understand valuation trends.
Brooks Laboratories Ltd in the last 5 years
Lowest (-31.36x)
January 11, 2024
Today (-16.43x)
May 9, 2025
Industry (53.76x)
May 9, 2025
Highest (-5.43x)
May 25, 2023
Today’s Price to Earnings Ratio: -16.43x
Brooks Laboratories Ltd Financials
Get the annual and quarterly financial summary of Brooks Laboratories Ltd, including revenue, profit, loss and more.
Brooks Laboratories Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Brooks Laboratories Ltd.
Brooks Laboratories Ltd Earnings Results
Brooks Laboratories Ltd’s net profit fell -17.78% since last year same period to ₹-4.57Cr in the Q3 2024-2025. On a quarterly growth basis, Brooks Laboratories Ltd has generated -15.4% fall in its net profits since last 3-months.
Read More about Earnings Results
Brooks Laboratories Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Brooks Laboratories Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 52.62% | 0.00 | |
| Foreign Institutions | 0.05% | 1907.41 | |
| Mutual Funds | 9.9% | 0.00 | |
| Retail Investors | 36.95% | ||
| Others | 0.48% | 0.00 |
Brooks Laboratories Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Brooks Laboratories Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 385.80 | 67.46% | 0.55 | -20 | 79 | |
| HOLD | 23,494.27 | -4.33% | 0.50 | 772 | 5,664 | |
| NA | 33.88 | -17.35% | 0.50 | 2 | 20 | |
| NA | 745.48 | 390.54% | 0.65 | 23 | 307 | |
| NA | 103.60 | 36.28% | 0.51 | 1 | 27 |
Insights on Brooks Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 year, BROOKS stock has moved up by 33.4%
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.00% to 0.05% in Mar 2025 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 18.0 Cr → 38.55 Cr (in ₹), with an average increase of 29.9% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 52.62% of holdings in Mar 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 54.1% return, outperforming this stock by 20.7%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 150.9% return, outperforming this stock by 77.1%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 3 quarters, -2.41 Cr → -4.57 Cr (in ₹), with an average decrease of 39.9% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 37.48% to 36.95% in Mar 2025 quarter
About Brooks Laboratories Ltd
Brooks Laboratories Ltd was established in January 2002 and it started operations and commercial production in May and June 2006 respectively. It obtained an ISO 9001:2008 Certificate in August 2007 and an Import License from Drugs Controller General of India in October 2006. On August 2011, they raised Rs. 63 crore through IPO and their shares officially listed on stock exchanges in September 2011.
Their current manufacturing facility at Baddi is 100% operational, with world class dedicated carbapenem facility in Vadodara Plant which commenced activity on 7 March 2017. Baddi facility was upgraded in June 2017 for 3 months, and production in injectable line resumed from September onwards. Finally, production commenced in August 2017 in the renovated building and was almost double than the previous line.
Revenue: ₹38.45Cr as on December 2024 (Q4 24)
Net Profit: ₹-4.57Cr as on December 2024 (Q4 24)
Listing date: 05 Sep, 2011
| Organisation | Brooks Laboratories Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Indian Mutual Funds that own Brooks Laboratories Ltd
Check out the Mutual Funds with significant holdings in Brooks Laboratories Ltd.
| Funds | Holdings | Prev. 5M |
|---|---|---|
| Quant Business Cycle Fund Direct Growth | 3.02% |
FAQs
What is Brooks Laboratories Ltd price today?
Brooks Laboratories Ltd share price today stands at ₹131.49, Open: ₹131, Previous Close: ₹130.97, High: ₹135.9, Low: ₹130, 52 Week High: ₹198.86, 52 Week Low: ₹73.25.
How to Buy Brooks Laboratories Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Brooks Laboratories Ltd shares
What are today's traded volumes of Brooks Laboratories Ltd?
Today's traded volume of Brooks Laboratories Ltd(BROOKS) is 20.13K.
What is today's market capitalisation of Brooks Laboratories Ltd?
Today's market capitalisation of Brooks Laboratories Ltd(BROOKS) is ₹385.80 Cr.
What is the 52 Week High and Low Range of Brooks Laboratories Ltd?
How much percentage Brooks Laboratories Ltd is down from its 52 Week High?
Brooks Laboratories Ltd (BROOKS) share price is ₹131.49. It is down -33.88% from its 52 Week High price of ₹198.86
How much percentage Brooks Laboratories Ltd is up from its 52 Week low?
Brooks Laboratories Ltd (BROOKS) share price is ₹131.49. It is up 79.51% from its 52 Week Low price of ₹73.25